Thromboembolic events during pregnancy remain a major cause of morbidity and mortality with possible catastrophic sequelae for the patient. The decision whether to use high-risk therapeutic thrombolytics during pregnancy or perinatally is complicated and many considerations pertain. We report on the thrombolytic management of a 34-year-old woman who had an asystolic cardiac arrest secondary to massive pulmonary embolism while undergoing emergency caesarean delivery. The patient was thrombolysed during successful cardiopulmonary resuscitation. Return of spontaneous circulation was accompanied by massive uterine bleeding. Instead of performing a postpartum hysterectomy, the uterus was preserved through continuous manual pressure and packing for four hours by the obstetric team until haemostasis was achieved. The patient survived and was later discharged without any major neurological deficit.
Thromboembolic events during pregnancy are a major cause of morbidity and mortality, with an estimated incidence of 0.76 to 1.72 per 1000 pregnancies 1, 2 . Despite increasing awareness of the risks associated with venous thromboembolism and greater use of thromboprophylaxis, pulmonary embolism (PE) remains the leading cause of maternal mortality in many developed countries and contributes to approximately one-fifth of all direct maternal deaths worldwide [3] [4] [5] [6] . The diagnosis remains challenging as symptoms are unreliable and the role of investigations unclear. Using vascular ultrasound to exclude deep venous thrombosis (DVT) in patients with lower leg symptoms as the primary (or only) investigation remains controversial due to the low sensitivity, which has led to multiple recommendations for the evaluation of leg symptoms during pregnancy 2 . Furthermore, Moser et al found that up to 40% of pregnant women with an asymptomatic DVT also had an asymptomatic PE 7 .
Pregnancy is a pro-thrombotic state in which increased fibrinogen concentration, decreased fibrinolytic activity and uterine compression of pelvic veins result in higher rates of DVT and PE [7] [8] [9] . Most anticoagulant agents, with the exception of heparin, are relatively contraindicated during pregnancy and perinatally, due to the risk of teratogenicity and haemorrhage. Thus the decision whether to use these high-risk therapeutic drugs in pregnancy or perinatally is highly complex and many considerations pertain.
We report on the thrombolytic management of a woman who had an asystolic cardiac arrest secondary to a massive PE while undergoing caesarean delivery.
CASE HISTORY
Consent to publish this case was obtained from the patient. A 34-year-old female was referred to the obstetric unit at St Franziskus Hospital at 33 weeks gestation in her first pregnancy. She presented with slight vaginal bleeding and a two-day history of right lower leg pain. She had a history of Graves' disease, but had been otherwise healthy and had no specific risk factors predisposing her to DVT. Her vital signs and cardiovascular and respiratory system examination were normal. Abdominal examination confirmed a term-size foetus in the cephalic presentation with a normal cardiotocographic foetal heart trace. Ultrasound studies of the leg performed by a vascular radiographer showed no evidence of a DVT, so the patient was then admitted to the antenatal ward for observation.
Later that day the patient suddenly became haemodynamically compromised. When the medical response team arrived, her peripheral oxygen saturation was below 80% on room air. She had sinus tachycardia, was hypotensive (77/35 mmHg), had severe tachypnoea and was unable to communicate adequately due to significant shortness of breath and confusion. Oxygen was delivered via a face mask and she was taken to theatre for an emergency caesarean delivery. General anaesthesia was induced using a rapid sequence technique with thiopentone (275 mg) and succinylcholine (100 mg). Inspiratory oxygen concentration was maintained at 100%. Two and a half minutes after induction and within about 15 minutes of the initial emergency call, a male infant was delivered with Apgar scores of 3, 8 and 9 at one, five and 10 minutes.
While the neonate's umbilical cord was being cut the patient developed a broad-complex ventricular tachycardia and seconds later became asystolic. Chest compressions were started; an arterial line was inserted into her right femoral artery and a central venous catheter into her left femoral vein. An arterial blood gas sample showed a pH 7.09, P a CO 2 of 76 mmHg, P a O 2 of 24 mmHg and a Hb of 120 g/l.
Resuscitation continued according to current International Liaison Committee on Resuscitation guidelines 10 . Adrenaline was given in one milligram boluses every three to four minutes. A transoesophageal echocardiogram was performed by the anaesthetist, which showed a distended right ventricle and atrium and ventricular standstill. Based on the history, clinical presentation and transoesophageal echocardiogram findings, a presumptive diagnosis of PE was made. Due to the poor clinical status of the patient, no further diagnostic investigations were undertaken. Following discussion with the obstetrician, the anaesthetist then commenced rescue thrombolysis.
At 19 minutes from the commencement of asystole, 10 IU of reteplase (Actavis, Munich, Germany) was administered, followed by a further 10 IU over 30 minutes. Seventeen minutes after the administration of reteplase (36 minutes after starting cardiopulmonary resuscitation) there was a return of spontaneous circulation, which was accompanied by severe uterine bleeding. Despite intravenous oxytocin (total of 30 IU), the bleeding was still so substantial that a postpartum hysterectomy was discussed. However, the obstetrician decided that all efforts should be made to preserve the uterus due to the patient's young age and known desire for more children. The anaesthetic team agreed to this based on the apparent stabilisation of the patient following the return of spontaneous circulation. A 'pack and wait' strategy was employed involving manual compression of the uterus and rigorous intrauterine packing applied for the next four hours until the bleeding stopped, avoiding the need for hysterectomy. Anaesthesia was maintained with continuous infusion of fentanyl, propofol and midazolam. Perioperatively, the patient received a total of 4000 ml of crystalloids, 3000 ml of colloid, 2100 ml of packed red blood cells, 2750 ml of fresh frozen plasma and two packs of platelets.
Hypothermia was induced, using cooled fluids, once bleeding was under control. The patient was then transferred to the intensive care unit where she was ventilated and her blood pressure supported by a noradrenaline infusion (1 mg/hour).
On arrival in the intensive care unit her body temperature was 31.3°C. Catecholamine requirements reduced quickly over the next three hours. Mild hypothermia (32 to 34°C) was maintained for 12 hours with no further major bleeding from the uterus. The patient was actively warmed to 37°C and then successfully extubated. On day three the patient was well orientated and discharged to the postnatal ward. She was reviewed by a neurologist and appeared free of any neurological deficit except retrograde amnesia from the time of admission to the antenatal ward.
DISCUSSION
We report on the management of a severe cardiovascular collapse due to PE that led to an emergency caesarean delivery and intraoperative cardiac arrest with subsequent thrombolysis undertaken during cardiopulmonary resuscitation. The current guidelines of the European Society of Cardiology recommend thrombolysis as the firstline treatment in patients with a high risk of PE who present in cardiogenic shock and/or persistent systemic hypotension 11 . These recommendations are mainly based on the fact that several early trials have demonstrated that thrombolytic therapy is more effective than heparinisation in restoring haemodynamic stability and decreasing clot exposure [12] [13] [14] . For pregnant women however, the current guidelines recommend administration of low-molecular-weight heparin and suggest that, especially at the time of delivery, thrombolytic treatment is avoided except in "extremely severe cases and if surgical embolectomy is not immediately available" 11 . Due to a strong negative charge, heparins do not cross the placenta to affect the foetus, making unfractionated and low-molecular-weight heparin the current standard treatment for DVT and PE during pregnancy. Other anticoagulant agents are relatively contraindicated during pregnancy and around the time of delivery. The teratogenicity for thrombolytic drugs in humans is uncertain and there is concern about possible foetal loss or maternal bleeding, especially due to uterine atony induced by elevated levels of fibrin degradation products [15] [16] [17] . Consequently, despite the frequency of DVT and PE, the number of reports of thrombolytic therapy for massive PE during pregnancy are limited, and there are none documenting its use for peripartum PE 3-6 . Considering the gravity of the underlying condition, the outcomes of reported thrombolysis during pregnancy for massive PE have actually been acceptable: no maternal deaths, five non-fatal maternal major bleeding complications, three foetal deaths and five preterm deliveries have been reported. The drugs used were streptokinase (n=6) and rtPA (n=7). Both these fibrinolytic drugs act on plasminogen, by cleavage to plasmin. Plasmin splits fibrin, fibrinogen, factor V and factor VIII inducing a "systemic lytic state" 18, 19 .
In our case, massive bleeding from the uterus following thrombolysis was anticipated and immediate hysterectomy considered, but due to the patient's age and primiparity, it was decided to try to preserve her uterus. To our knowledge, this is the first case report of an intraoperative thrombolysis where hysterectomy was avoided. Kukla et al reported a thrombolysis during pregnancy in a 27-year-old woman, complicated by massive uterine bleeding for which a hysterectomy was performed at 27 weeks gestation 20 .
For many years, surgical embolectomy was the only available alternative to heparin therapy for patients with massive PE. We found 12 case reports related to surgical embolectomy during pregnancy, describing no maternal, but four foetal deaths. There are no clear indications for surgical embolectomy in otherwise healthy patients and there is no information during pregnancy, but the significant foetal mortality associated with the procedure probably suggests that surgical embolectomy, if feasible at all, should probably be reserved for failed or contraindicated thrombolysis.
Catheter-directed thrombolysis (with or without mechanical embolectomy or fragmentation) is a relatively new procedure, still considered experimental, which requires special facilities and expertise and is not feasible in the emergency situation.
Induced mild hypothermia for 12 to 24 hours after cardiac arrest has been associated with a significantly better neurological outcome 21, 22 . However, hypothermia is also known to affect coagulation and thus increase the risk of bleeding. When weighing the risks of a re-bleed against the possibility of an improved neurological outcome, we agreed that with the option of immediate hysterectomy available we would always be in a position to cope with a possible re-bleed from the uterus and we therefore induced mild hypothermia.
In our case, previous ultrasound investigation of the leg had not shown abnormalities indicative of DVT. Reviewing the available literature it appears that the role of lower extremity vascular ultrasound remains controversial, due to a low sensitivity and a high rate of negative results, which has led to recommendations in some centres to start the diagnostic work-up with a ventilation-perfusion scan, and possibly skip the vascular ultrasound 2 .
In a case of life-threatening cardiovascular or respiratory compromise due to PE during pregnancy and/or delivery, rescue thrombolysis is a possible option that may be worth considering. However, the potential for massive obstetric bleeding and further side-effects must be considered and adequate strategies and resources should be available. Overall, it remains questionable whether current evidence justifies withholding thrombolytic therapy from pregnant women experiencing a lifethreatening PE.
